XML 22 R6.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Trinity Warrants
Additional Paid-in Capital
Additional Paid-in Capital
Trinity Warrants
Accumulated Other Comprehensive Loss
Accumulated Deficit
Common Stock
Common Stock
Common Stock
Common Stock
Trinity Warrants
Common Stock
Common Stock
SVB Warrants
Class F Stock
Common Stock
Beginning balance (in shares) at Dec. 31, 2021 5,307,857                  
Beginning balance at Dec. 31, 2021 $ 99,470                  
Increase (Decrease) in Temporary Equity [Roll Forward]                    
Conversion of convertible preferred stock to common stock (in shares) (5,307,857)                  
Conversion of convertible preferred stock to common stock $ (99,470)                  
Ending balance (in shares) at Dec. 31, 2022 0                  
Ending balance at Dec. 31, 2022 $ 0                  
Balance (in shares) at Dec. 31, 2021             6,764,531     2,050,534
Balance at Dec. 31, 2021 (87,531)   $ 7,951   $ (43) $ (95,439) $ 0     $ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Conversion of convertible preferred stock to common stock (in shares)             5,307,857      
Conversion of convertible preferred stock to common stock 99,470   99,470       $ 0      
Conversion of class F stock to common stock (in shares)             (2,050,534)     (2,050,534)
Reverse recapitalization, net of transaction costs (in shares)             1,184,594      
Reverse recapitalization, net of transaction costs (33,142)   (33,142)       $ 0      
Exercise of stock options and release of RSUs (in shares)             199,563      
Exercise of stock options and release of RSUs 1,110   1,110              
Issuance of common stock to LPC (in shares)             129,250      
Issuance of common stock to LPC 1,880   1,880              
Exercise of warrants (in shares)               23,757 14,695  
Exercise of warrants   $ 547   $ 547            
Stock-based compensation expense 8,258   8,258              
Unrealized gain/loss on available-for-sale securities, net of tax (6)       (6)          
Capital contribution from Secured Term Loan Agreement 1,984   1,984              
Cumulative translation adjustment (317)       (317)          
Net income (loss) 9,380         9,380        
Balance (in shares) at Dec. 31, 2022             15,674,781     0
Balance at Dec. 31, 2022 $ 1,633   88,058   (366) (86,059) $ 0     $ 0
Increase (Decrease) in Temporary Equity [Roll Forward]                    
Issuance of convertible preferred stock, net of transaction costs (in shares) 100,000                  
Issuance of convertible preferred stock, net of transaction costs $ 98,891                  
Ending balance (in shares) at Dec. 31, 2023 100,000                  
Ending balance at Dec. 31, 2023 $ 98,891                  
Increase (Decrease) in Stockholders' Equity [Roll Forward]                    
Exercise of stock options and release of RSUs (in shares)             203,762      
Exercise of stock options and release of RSUs 31   31              
Stock-based compensation expense 8,557   8,557              
Unrealized gain/loss on available-for-sale securities, net of tax 2       2          
Vesting of early exercised options (in shares)             (17,049)      
Payments of employee taxes related to vested restricted stock units (63)   (63)              
Cumulative translation adjustment 19       19          
Net income (loss) (48,546)         (48,546)        
Balance (in shares) at Dec. 31, 2023             15,861,494     0
Balance at Dec. 31, 2023 $ (38,367)   $ 96,583   $ (345) $ (134,605) $ 0     $ 0